The healthcare sector in 2026 is witnessing a significant resurgence in tissue-based diagnostics. As per the latest Liver Biopsy Market analysis, while non-invasive imaging has become a standard first-line screening tool, the clinical "gold standard" remains the physical biopsy for definitive staging and therapeutic monitoring. This steadfast reliance is reflected in the Liver Biopsy Market...